Abstract:As a typical case of the optimal planning for the provision of restricted medical resources, widespread vaccination is considered an effective and sustainable way to prevent and control large-scale novel coronavirus disease 2019 (COVID-19) outbreaks. However, an initial supply shortage of vaccines is inevitable because of the narrow production and logistical capacity. This work focuses on the multi-type vaccine resource allocation problem in a two-dose vaccination campaign under limited supply. To address this issue, we extended an age-stratified susceptible, exposed, infectious, and recovered (SEIR) epidemiological model to incorporate a two-dose vaccination campaign involving multiple vaccine types to fully characterize the various stages of infection and vaccination. Afterward, we integrated the proposed epidemiological model into a nonlinear programming (NLP) model to determine the optimal allocation strategy under supply capacity and vaccine hesitancy constraints with the goal of minimizing the cumulative number of deaths due to the pandemic over the entire planning horizon. A case study based on real-world data from the initial mass vaccination campaign against COVID-19 in the Midlands, England, was taken to validate the applicability of our model. Then, we performed a comparative study to demonstrate the performance of the proposed method and conducted an extensive sensitivity analysis on critical model parameters. Our results indicate that prioritizing the allocation of vaccines to elderly persons is an effective strategy for reducing COVID-19-related fatalities. Furthermore, we found that vaccination alone will not be sufficient for epidemic control in the short term, and appropriate non-pharmacological interventions are still important for effective viral containment during the initial vaccine rollout. The results also showed that the relative efficacy of the first dose is a vital factor affecting the optimal interval between doses. It is always best to complete the two-dose vaccination schedule as soon as possible when the relative efficacy of the first dose is low. Conversely, delaying the second dose of a vaccine as long as possible to increase the proportion of the population vaccinated with a single dose tends to be more favorable when the relative efficacy of the first dose is high. Finally, our proposed model is general and easily extendable to the study of other infectious disease outbreaks and provides important implications for public health authorities seeking to develop effective vaccine allocation strategies for tackling possible future pandemics.

Fairness versus efficiency of vaccine allocation strategies

Vaccination for communicable endemic diseases: optimal allocation of initial and booster vaccine doses

Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions

International Vaccine Allocation: An Optimization Framework

How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework

Influenza vaccine allocation in tropical settings under constrained resources

A Comparative Analysis of Influenza Vaccination Programs

Strategic COVID-19 vaccine distribution can simultaneously elevate social utility and equity

An Integrated Vaccination Site Selection and Dose Allocation Problem with Fairness Concerns

Who should get vaccinated? Individualized allocation of vaccines over SIR network

Influenza vaccination allocation in tropical settings under constrained resources

Optimal Allocation of Multi-Type Vaccines in a Two-Dose Vaccination Campaign for Epidemic Control: A Case Study of COVID-19

The futility of being selfish in vaccine distribution

Design of Targeted Community-Based Resource Allocation in the Presence of Vaccine Hesitancy via a Data-Driven Compartmental Stochastic Optimization Model

The most efficient critical vaccination coverage and its equivalence with maximizing the herd effect

An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic

Balancing the Benefits of Vaccination: an Envy-Free Strategy

Fair treatment allocations in social networks

Optimal vaccination at high reproductive numbers: sharp transitions and counter-intuitive allocations

An optimization model for influenza A epidemics

Optimal Vaccine Allocation for Pandemic Stabilization